Keywordsdeep brain stimulation; obesity; hypothalamus; nucleus accumbens; amygdala; basolateral nucleus; deep brain stimulation; microelectrode recording; PTSD; targeting technique; deep brain stimulation; autonomic dysfunction; subthalamic nucleus; periaqueductal or periventricular gray; globus pallidus interna; thalamus; blood pressure; sweating; micturition; gastrointestinal motility; Deep Brain Stimulation (DBS); stimulation frequency; discrete nonlinear oscillators; stochastic resonance; basal ganglia–thalamic–cortical system of oscillators; Principle of Causational Synonymy; Principle of Informational Synonymy; Tourette syndrome; TS deep brain stimulation; DBS; chorea; Huntington; deep brain stimulation; DBS; safety pathophysiology; recordings; globus pallidus; deep brain stimulation (DBS); steering; patient-specific; electric field; finite element method; neuron model; brain model; zona incerta (ZI); electrode design; deep brain stimulation; personality; instruments; competencies; Parkinson’s disease; essential tremor; dystonia; deep brain stimulation; treatment failure; rescue leads; deep brain stimulation; awake DBS; ventral intermediate nucleus; VIM; dysphonia; essential tremor; essential vocal tremor; EVT; voice; tremulous voice; laryngoscopy; acoustic analysis; microelectrode recording; Parkinson’s disease (PD); local field potential (LFP); deep brain stimulation (DBS); beta frequency oscillations; subthalamic nucleus; closed-loop; subthalamic nucleus; deep brain stimulation; Parkinson’s disease; neuromodulation; clinical outcome; subthalamic nucleus; deep brain stimulation; targeting; Parkinson’s disease; planning; deep brain stimulation; CMPf; PAG/PVG; pain; pain pathways; spinal cord injury; spinal cord stimulation; deep brain stimulation; neuromodulation; animal model; gamma frequency oscillations; glutamate; ketamine; network synchrony; N-methyl-d-aspartate; psychosis; sleep spindles; thalamic reticular nucleus; thalamus
